Menu Menu
News

Message from the Chair & Executive Director

20 December, 2022

Dear colleagues,

This year has been filled with both achievements and challenges. While there have been many changes, the impact of the pandemic continues to be substantial, especially those working in healthcare.

In this ever-changing environment, and with your help and support, the Taskforce has continued to provide up-to-date, independent, evidence-based guidance for clinicians on how to best care for people with and after COVID-19.

We are also proud of the success we have had in extending our scope to cover urgent and emerging diseases beyond COVID-19, with the first set of treatment guidelines for MPX being published in October this year.

None of this would be possible without the commitment of our 35 member organisations, over 200 expert clinicians and consumers who generously contribute their time and expertise. We are so grateful, for their continued commitment, and especially in accommodating tight deadlines in the midst of their own heavy workloads and life commitments.

We recognise the contributions of our partners: School of Public Health and Preventive Medicine, Monash University, Cochrane, Consumers Health Forum of Australia, Australian Commission on Safety and Quality in Health Care, Australian Living Evidence Consortium, Covidence, MAGICapp and NPS MedicineWise.

We would like to also acknowledge our dedicated Taskforce team for another year of incredible work.

Lastly, we thank our funders – the Australian Government Department of Health and Aged Care, and the Walter Cottman Endowment Fund, managed by Equity Trustees for recognising the value of living guidelines and the importance of evidence-based guidance. Unfortunately, as shared in our funding update last week, the Commonwealth Department of Health and Aged Care has advised they will not be continuing our contract to develop clinical guidelines for COVID-19 beyond December 31, 2022

We believe up-to-date guidance to support clinicians caring for people with COVID-19 continues to be vital and are currently seeking sources of funding to continue our work in 2023. We will be sure to keep you informed as this develops.

We thank you for your continuing support and wish you a safe and happy summer break.

 

Topics